Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Modulation of limbic circuitry predicts treatment response to antipsychotic medication: a functional imaging study in schizophrenia.

Lahti AC, Weiler MA, Holcomb HH, Tamminga CA, Cropsey KL.

Neuropsychopharmacology. 2009 Dec;34(13):2675-90. doi: 10.1038/npp.2009.94. Epub 2009 Aug 12.

2.

Functional effects of single dose first- and second-generation antipsychotic administration in subjects with schizophrenia.

Lahti AC, Weiler MA, Medoff DR, Tamminga CA, Holcomb HH.

Psychiatry Res. 2005 May 30;139(1):19-30.

PMID:
15950442
3.

Functional effects of antipsychotic drugs: comparing clozapine with haloperidol.

Lahti AC, Holcomb HH, Weiler MA, Medoff DR, Tamminga CA.

Biol Psychiatry. 2003 Apr 1;53(7):601-8.

PMID:
12679238
4.

Clozapine but not haloperidol Re-establishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex.

Lahti AC, Holcomb HH, Weiler MA, Medoff DR, Frey KN, Hardin M, Tamminga CA.

Neuropsychopharmacology. 2004 Jan;29(1):171-8.

5.

Antipsychotic drug effects on brain morphology in first-episode psychosis.

Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, Keefe RS, Green AI, Gur RE, McEvoy J, Perkins D, Hamer RM, Gu H, Tohen M; HGDH Study Group.

Arch Gen Psychiatry. 2005 Apr;62(4):361-70.

PMID:
15809403
6.

Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia.

Miller DD, Andreasen NC, O'Leary DS, Watkins GL, Boles Ponto LL, Hichwa RD.

Biol Psychiatry. 2001 Apr 15;49(8):704-15.

PMID:
11313038
7.

The effect of clozapine on regional cerebral blood flow and brain metabolite ratios in schizophrenia: relationship with treatment response.

Ertugrul A, Volkan-Salanci B, Basar K, Karli Oguz K, Demir B, Ergun EL, Senturk S, Erbas B, Cila A, Ulug B.

Psychiatry Res. 2009 Nov 30;174(2):121-9. doi: 10.1016/j.pscychresns.2009.04.007. Epub 2009 Oct 17.

PMID:
19837567
8.

Cerebral blood flow changes in very-late-onset schizophrenia-like psychosis with catatonia before and after successful treatment.

Tsujino N, Nemoto T, Yamaguchi T, Katagiri N, Tohgi N, Ikeda R, Shiraga N, Mizumura S, Mizuno M.

Psychiatry Clin Neurosci. 2011 Oct;65(6):600-3. doi: 10.1111/j.1440-1819.2011.02257.x.

9.

Stability of emotional dysfunctions? A long-term fMRI study in first-episode schizophrenia.

Reske M, Kellermann T, Habel U, Jon Shah N, Backes V, von Wilmsdorff M, Stöcker T, Gaebel W, Schneider F.

J Psychiatr Res. 2007 Dec;41(11):918-27. Epub 2007 Apr 27.

PMID:
17467008
10.

Early effects of treatment on regional cerebral blood flow in first episode schizophrenia patients evaluated with 99Tc-ECD-SPECT.

Novak B, Milcinski M, Grmek M, Kocmur M.

Neuro Endocrinol Lett. 2005 Dec;26(6):685-9.

PMID:
16380684
11.

Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol.

Holcomb HH, Cascella NG, Thaker GK, Medoff DR, Dannals RF, Tamminga CA.

Am J Psychiatry. 1996 Jan;153(1):41-9.

PMID:
8540590
12.
13.

Tc-99 HMPAO SPECT study of regional cerebral blood flow in olanzapine-treated schizophrenic patients.

Gonul AS, Kula M, Sofuoglu S, Tutus A, Esel E.

Eur Arch Psychiatry Clin Neurosci. 2003 Feb;253(1):29-33.

PMID:
12664310
14.

Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol.

Lieberman JA, Tollefson G, Tohen M, Green AI, Gur RE, Kahn R, McEvoy J, Perkins D, Sharma T, Zipursky R, Wei H, Hamer RM; HGDH Study Group.

Am J Psychiatry. 2003 Aug;160(8):1396-404.

PMID:
12900300
15.

Probing the human hippocampus using rCBF: contrasts in schizophrenia.

Medoff DR, Holcomb HH, Lahti AC, Tamminga CA.

Hippocampus. 2001;11(5):543-50.

PMID:
11732707
17.

Effect of antipsychotic drugs on cortical thickness. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine.

Roiz-Santiáñez R, Tordesillas-Gutiérrez D, Ortíz-García de la Foz V, Ayesa-Arriola R, Gutiérrez A, Tabarés-Seisdedos R, Vázquez-Barquero JL, Crespo-Facorro B.

Schizophr Res. 2012 Oct;141(1):22-8. doi: 10.1016/j.schres.2012.07.014. Epub 2012 Aug 11.

PMID:
22884754
18.

Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol.

Tollefson GD, Sanger TM, Lu Y, Thieme ME.

Arch Gen Psychiatry. 1998 Mar;55(3):250-8. Erratum in: Arch Gen Psychiatry 1998 Nov;55(11):1052.

PMID:
9510219
19.

Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.

Dossenbach M, Pecenak J, Szulc A, Irimia V, Anders M, Logozar-Perkovic D, Peciukaitiene D, Kotler M, Smulevich AB, West TM, Lowry AJ, Treuer T.

J Clin Psychiatry. 2008 Dec;69(12):1901-15. Epub 2008 Sep 9.

PMID:
19012820
20.

A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.

Crespo-Facorro B, Pérez-Iglesias R, Ramirez-Bonilla M, Martínez-García O, Llorca J, Luis Vázquez-Barquero J.

J Clin Psychiatry. 2006 Oct;67(10):1511-21.

PMID:
17107241

Supplemental Content

Support Center